OABI (OmniAb) Institutional Ownership: 42.47% (As of Jul. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OABI OmniAb Inc OABI
72 GF Score
Price $1.99
GF Value $2.27
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is OmniAb Institutional Ownership?

OmniAb OABI +0.51% 72 Institutional Ownership is 42.47% as of Jul. 31, 2026. GuruFocus rates OABI with a GF Score™ of 72/100 and a GF Value™ of $2.27 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, OmniAb's institutional ownership is 42.47%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, OmniAb's Insider Ownership is 5.91%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, OmniAb's Float Percentage Of Total Shares Outstanding is 91.11%.

OmniAb Institutional Ownership Historical Data

* Premium members only.

The historical data trend for OmniAb's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OmniAb Institutional Ownership Chart

OmniAb Historical Data

The historical data trend for OmniAb can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 17.60 17.33 17.28 17.74 17.49 17.41 17.74 17.44 17.25 17.86
OABI
72GF Score
OmniAb Inc OABI
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OmniAb Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 42.47% mean?
OmniAb (OABI) has a Institutional Ownership of 42.47% as of Jul. 31, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on OmniAb and its competitors.
Is OmniAb's Institutional Ownership too high?
OmniAb's current Institutional Ownership is 42.47%. Overall, OmniAb has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does OmniAb's Institutional Ownership compare to FHTX and PRLD?
OmniAb's Institutional Ownership of 42.47% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on OmniAb and its competitors. OmniAb's current Institutional Ownership is 42.47%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OmniAb stock overvalued right now?
Based on GuruFocus' analysis, OmniAb (OABI) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.27, compared to a current price of $1.99 — trading 12.3% below its estimated fair value. The current Institutional Ownership is 42.47%. OmniAb's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For OmniAb (OABI), the current Institutional Ownership is 42.47% as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OmniAb (OABI) Overvalued in 2026?

Based on GuruFocus' analysis, OmniAb stock appears to be undervalued. The current stock price of $1.99 is trading 12.3% below its estimated GF Value™ of $2.27. GuruFocus considers OmniAb to be Modestly Undervalued.

Key valuation signals for OABI:

  • Institutional Ownership: 42.47%
  • GF Value™: $2.27 vs. price of $1.99 (12.3% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the OABI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OmniAb Business Description

Address 5980 Horton Street, Suite 600, Emeryville, CA, USA, 94608
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
72GF Score

Get the complete analysis for OABI

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.99
Price
$2.27
GF Value